Unnatural amino acid incorporation in E. coli: Current and future applications in the design of therapeutic proteins

Frontiers in Chemistry

Volumn 2, Issue APR, 2014, Pages

  Wals, Kim ^a   Ovaa, Huib ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Amber codon suppression; Antibody conjugates; Chemical protein modifications; Escherichia coli; Release factor 1; Therapeutic proteins; Unnatural amino acid incorporation

Indexed keywords

EID: 84987624307     PISSN: None     EISSN: 22962646     Source Type: Journal    
DOI: 10.3389/fchem.2014.00015     Document Type: Review

References (95)

1. Anderson, J. C., Magliery, T. J., and Schultz, P. G. (2002). Exploring the limits of codon and anticodon size. Chem. Biol. 9, 237-244. doi: 10.1016/S1074-5521(02)00094-7
2. Armen, R. S., Schiller, S. M., and Brooks, C. L. 3rd. (2010). Steric and thermodynamic limits of design for the incorporation of large unnatural amino acids in aminoacyl-tRNA synthetase enzymes. Proteins 78, 1926-1938. doi: 10.1002/prot.22706
3. Axup, J. Y., Bajjuri, K. M., Ritland, M., Hutchins, B. M., Kim, C. H., Kazane, S. A., et al. (2012). Synthesis of site-specific antibody-drug conjugates using unnatural amino acids. Proc. Natl. Acad. Sci. U.S.A. 109, 16101-16106. doi: 10.1073/pnas.1211023109
4. Banta, S., Dooley, K., and Shur, O. (2013). Replacing antibodies: engineering new binding proteins. Annu. Rev. Biomed. Eng. 15, 93-113. doi: 10.1146/annurev-bioeng-071812-152412
5. Bayly, A. M., Kortt, A. A., Hudson, P. J., and Power, B. E. (2002). Large-scale bacterial fermentation and isolation of scFv multimers using a heat-inducible bacterial expression vector. J. Immunol. Methods 262, 217-227. doi: 10.1016/S0022-1759(02)00021-2
6. Bernardes, G. J., Casi, G., Trussel, S., Hartmann, I., Schwager, K., Scheuermann, J., et al. (2012). A traceless vascular-targeting antibody-drug conjugate for cancer therapy. Angew. Chem. Int. Ed. Engl. 51, 941-944. doi: 10.1002/anie.201106527
7. Best, M. D. (2009). Click chemistry and bioorthogonal reactions: unprecedented selectivity in the labeling of biological molecules. Biochemistry 48, 6571-6584. doi: 10.1021/bi9007726
8. Boder, E. T., Midelfort, K. S., and Wittrup, K. D. (2000). Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. Proc. Natl. Acad. Sci. U.S.A. 97, 10701-10705. doi: 10.1073/pnas.170297297
9. Budisa, N. (2004). Prolegomena to future experimental efforts on genetic code engineering by expanding its amino acid repertoire. Angew. Chem. Int. Ed. Engl. 43, 6426-6463. doi: 10.1002/anie.200300646
10. Cellitti, S. E., Jones, D. H., Lagpacan, L., Hao, X., Zhang, Q., Hu, H., et al. (2008). In vivo incorporation of unnatural amino acids to probe structure, dynamics, and ligand binding in a large protein by nuclear magnetic resonance spectroscopy. J. Am. Chem. Soc. 130, 9268-9281. doi: 10.1021/ja801602q
11. Chames, P., and Baty, D. (2009). Bispecific antibodies for cancer therapy: the light at the end of the tunnel? MAbs 1, 539-547. doi: 10.4161/mabs.1.6.10015
12. Chari, R. V. (2008). Targeted cancer therapy: conferring specificity to cytotoxic drugs. Acc. Chem. Res. 41, 98-107. doi: 10.1021/ar700108g
13. Chatterjee, A., Sun, S. B., Furman, J. L., Xiao, H., and Schultz, P. G. (2013). A versatile platform for single-and multiple-unnatural amino acid mutagenesis in Escherichia coli. Biochemistry 52, 1828-1837. doi: 10.1021/bi4000244
14. Cho, H., Daniel, T., Buechler, Y. J., Litzinger, D. C., Maio, Z., Putnam, A. M., et al. (2011). Optimized clinical performance of growth hormone with an expanded genetic code. Proc. Natl. Acad. Sci. U.S.A. 108, 9060-9065. doi: 10.1073/pnas.1100387108
15. Cho, H. S., Mason, K., Ramyar, K. X., Stanley, A. M., Gabelli, S. B., Denney, D. W., et al. (2003). Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421, 756-760. doi: 10.1038/nature01392
16. Choe, H., Li, W., Wright, P. L., Vasilieva, N., Venturi, M., Huang, C. C., et al. (2003). Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. Cell 114, 161-170. doi: 10.1016/S0092-8674(03)00508-7
17. Daniels, T. R., Delgado, T., Rodriguez, J. A., Helguera, G., and Penichet, M. L. (2006). The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin. Immunol. 121, 144-158. doi: 10.1016/j.clim.2006.06.010
18. de Graaf, A. J., Kooijman, M., Hennink, W. E., and Mastrobattista, E. (2009). Nonnatural amino acids for site-specific protein conjugation. Bioconjug. Chem. 20, 1281-1295. doi: 10.1021/bc800294a
19. Deiters, A., Cropp, T. A., Summerer, D., Mukherji, M., and Schultz, P. G. (2004). Site-specific PEGylation of proteins containing unnatural amino acids. Bioorg. Med. Chem. Lett. 14, 5743-5745. doi: 10.1016/j.bmcl.2004.09.059
20. de Oliveira, J. E., Soares, C. R., Peroni, C. N., Gimbo, E., Camargo, I. M., Morganti, L., et al. (1999). High-yield purification of biosynthetic human growth hormone secreted in Escherichia coli periplasmic space. J. Chromatogr. A 852, 441-450. doi: 10.1016/S0021-9673(99)00613-5
21. Dhomen, N. S., Mariadason, J., Tebbutt, N., and Scott, A. M. (2012). Therapeutic targeting of the epidermal growth factor receptor in human cancer. Crit. Rev. Oncog. 17, 31-50. doi: 10.1615/CritRevOncog.v17.i1.40
22. Gerdes, S. Y., Scholle, M. D., Campbell, J. W., Balazsi, G., Ravasz, E., Daugherty, M. D., et al. (2003). Experimental determination and system level analysis of essential genes in Escherichia coli MG1655. J. Bacteriol. 185, 5673-5684. doi: 10.1128/JB.185.19.5673-5684.2003
23. Guzman, L. M., Belin, D., Carson, M. J., and Beckwith, J. (1995). Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J. Bacteriol. 177, 4121-4130.
24. Hakim, R., and Benhar, I. (2009). "Inclonals": IgGs and IgG-enzyme fusion proteins produced in an E. coli expression-refolding system. MAbs 1, 281-287. doi: 10.4161/mabs.1.3.8492
25. Hendrickson, T. L., de Crecy-Lagard, V., and Schimmel, P. (2004). Incorporation of nonnatural amino acids into proteins. Annu. Rev. Biochem. 73, 147-176. doi: 10.1146/annurev.biochem.73.012803.092429
26. Hermeling, S., Crommelin, D. J. A., Schellekens, H., and Jiskoot, W. (2004). Structure-immunogenicity relationships of therapeutic proteins. Pharm. Res. 21, 897-903. doi: 10.1023/B:PHAM.0000029275.41323.a6
27. Hoogenboom, H. R. (2005). Selecting and screening recombinant antibody libraries. Nat. Biotechnol. 23, 1105-1116. doi: 10.1038/nbt1126
28. Huang, C. J., Lin, H., and Yang, X. (2012). Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements. J. Ind. Microbiol. Biotechnol. 39, 383-399. doi: 10.1007/s10295-011-1082-9
29. Isaacs, F. J., Carr, P. A., Wang, H. H., Lajoie, M. J., Sterling, B., Kraal, L., et al. (2011). Precise manipulation of chromosomes in vivo enables genome-wide codon replacement. Science 333, 348-353. doi: 10.1126/science.1205822
30. Jewett, J. C., and Bertozzi, C. R. (2010). Cu-free click cycloaddition reactions in chemical biology. Chem. Soc. Rev. 39, 1272-1279. doi: 10.1039/b901970g
31. Johnson, D. B., Wang, C., Xu, J., Schultz, M. D., Schmitz, R. J., Ecker, J. R., et al. (2012). Release factor one is nonessential in Escherichia coli. ACS Chem. Biol. 7, 1337-1344. doi: 10.1021/cb300229q
32. Johnson, D. B., Xu, J., Shen, Z., Takimoto, J. K., Schultz, M. D., Schmitz, R. J., et al. (2011). RF1 knockout allows ribosomal incorporation of unnatural amino acids at multiple sites. Nat. Chem. Biol. 7, 779-786. doi: 10.1038/nchembio.657
33. Jung, S. T., Kang, T. H., Kelton, W., and Georgiou, G. (2011). Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy. Curr. Opin. Biotechnol. 22, 858-867. doi: 10.1016/j.copbio.2011.03.002
34. Junutula, J. R., Raab, H., Clark, S., Bhakta, S., Leipold, D. D., Weir, S., et al. (2008). Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index. Nat. Biotechnol. 26, 925-932. doi: 10.1038/nbt.1480
35. Kim, C. H., Axup, J. Y., Dubrovska, A., Kazane, S. A., Hutchins, B. A., Wold, E. D., et al. (2012). Synthesis of bispecific antibodies using genetically encoded unnatural amino acids. J. Am. Chem. Soc. 134, 9918-9921. doi: 10.1021/ja303904e
36. Kruszewska, J. S., Perlinska-Lenart, U., Gorka-Niec, W., Orlowski, J., Zembek, P., and Palamarczyk, G. (2008). Alterations in protein secretion caused by metabolic engineering of glycosylation pathways in fungi. Acta Biochim. Pol. 55, 447-456.
37. Leader, B., Baca, Q. J., and Golan, D. E. (2008). Protein therapeutics: a summary and pharmacological classification. Nat. Rev. Drug Discov. 7, 21-39. doi: 10.1038/nrd2399
38. Li, H., Sethuraman, N., Stadheim, T. A., Zha, D., Prinz, B., Ballew, N., et al. (2006). Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nat. Biotechnol. 24, 210-215. doi: 10.1038/nbt1178
39. Lim, R. K., and Lin, Q. (2010). Bioorthogonal chemistry: recent progress and future directions. Chem. Commun. (Camb.) 46, 1589-1600. doi: 10.1039/b925931g
40. Liu, C. C., Brustad, E., Liu, W., and Schultz, P. G. (2007). Crystal structure of a biosynthetic sulfo-hirudin complexed to thrombin. J. Am. Chem. Soc. 129, 10648-10649. doi: 10.1021/ja0735002
41. Liu, C. C., Choe, H., Farzan, M., Smider, V. V., and Schultz, P. G. (2009a). Mutagenesis and evolution of sulfated antibodies using an expanded genetic code. Biochemistry 48, 8891-8898. doi: 10.1021/bi9011429
42. Liu, C. C., Mack, A. V., Brustad, E. M., Mills, J. H., Groff, D., Smider, V. V., et al. (2009b). Evolution of proteins with genetically encoded "chemical warheads." J. Am. Chem. Soc. 131, 9616-9617. doi: 10.1021/ja902985e
43. Liu, C. C., Mack, A. V., Tsao, M. L., Mills, J. H., Lee, H. S., Choe, H., et al. (2008). Protein evolution with an expanded genetic code. Proc. Natl. Acad. Sci. U.S.A. 105, 17688-17693. doi: 10.1073/pnas.0809543105
44. Liu, C. C., and Schultz, P. G. (2010). Adding new chemistries to the genetic code. Annu. Rev. Biochem. 79, 413-444. doi: 10.1146/annurev.biochem.052308.105824
45. Lopes, A. M., Magalhaes, P. O., Mazzola, P. G., Rangel-Yagui, C. O., de Carvalho, J. C., Penna, T. C., et al. (2010). LPS removal from an E. coli fermentation broth using aqueous two-phase micellar system. Biotechnol. Prog. 26, 1644-1653. doi: 10.1002/btpr.463
46. Makino, T., Skretas, G., Kang, T. H., and Georgiou, G. (2011). Comprehensive engineering of Escherichia coli for enhanced expression of IgG antibodies. Metab. Eng. 13, 241-251. doi: 10.1016/j.ymben.2010.11.002
47. Mazor, Y., Van Blarcom, T., Carroll, S., and Georgiou, G. (2010). Selection of full-length IgGs by tandem display on filamentous phage particles and Escherichia coli fluorescence-activated cell sorting screening. FEBS J. 277, 2291-2303. doi: 10.1111/j.1742-4658.2010.07645.x
48. Mazor, Y., Van Blarcom, T., Iverson, B. L., and Georgiou, G. (2008). E-clonal antibodies: selection of full-length IgG antibodies using bacterial periplasmic display. Nat. Protoc. 3, 1766-1777. doi: 10.1038/nprot.2008.176
49. Mazor, Y., Van Blarcom, T., Mabry, R., Iverson, B. L., and Georgiou, G. (2007). Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli. Nat. Biotechnol. 25, 563-565. doi: 10.1038/nbt1296
50. Melancon, C. E. 3rd., and Schultz, P. G. (2009). One plasmid selection system for the rapid evolution of aminoacyl-tRNA synthetases. Bioorg. Med. Chem. Lett. 19, 3845-3847. doi: 10.1016/j.bmcl.2009.04.007
51. Meldal, M., and Tornoe, C. W. (2008). Cu-catalyzed azide-alkyne cycloaddition. Chem. Rev. 108, 2952-3015. doi: 10.1021/cr0783479
52. Mukai, T., Hayashi, A., Iraha, F., Sato, A., Ohtake, K., Yokoyama, S., et al. (2010). Codon reassignment in the Escherichia coli genetic code. Nucleic Acids Res. 38, 8188-8195. doi: 10.1093/nar/gkq707
53. Nakamura, Y., Gojobori, T., and Ikemura, T. (2000). Codon usage tabulated from international DNA sequence databases: status for the year 2000. Nucleic Acids Res. 28, 292. doi: 10.1093/nar/28.1.292
54. Neumann, H. (2012). Rewiring translation-Genetic code expansion and its applications. FEBS Lett. 586, 2057-2064. doi: 10.1016/j.febslet.2012.02.002
55. Neumann, H., Hancock, S. M., Buning, R., Routh, A., Chapman, L., Somers, J., et al. (2009). A method for genetically installing site-specific acetylation in recombinant histones defines the effects of H3 K56 acetylation. Mol. Cell 36, 153-163. doi: 10.1016/j.molcel.2009.07.027
56. Neumann, H., Peak-Chew, S. Y., and Chin, J. W. (2008). Genetically encoding N(epsilon)-acetyllysine in recombinant proteins. Nat. Chem. Biol. 4, 232-234. doi: 10.1038/nchembio.73
57. Neumann, H., Wang, K., Davis, L., Garcia-Alai, M., and Chin, J. W. (2010). Encoding multiple unnatural amino acids via evolution of a quadruplet-decoding ribosome. Nature 464, 441-444. doi: 10.1038/nature08817
58. Nguyen, D. P., Garcia Alai, M. M., Kapadnis, P. B., Neumann, H., and Chin, J. W. (2009). Genetically encoding N(epsilon)-methyl-L-lysine in recombinant histones. J. Am. Chem. Soc. 131, 14194-14195. doi: 10.1021/ja906603s
59. Noren, C. J., Anthony-Cahill, S. J., Griffith, M. C., and Schultz, P. G. (1989). A general method for site-specific incorporation of unnatural amino acids into proteins. Science 244, 182-188. doi: 10.1126/science.2649980
60. Normanly, J., Kleina, L. G., Masson, J. M., Abelson, J., and Miller, J. H. (1990). Construction of Escherichia coli amber suppressor tRNA genes. III. Determination of tRNA specificity. J. Mol. Biol. 213, 719-726. doi: 10.1016/S0022-2836(05)80258-X
61. Payne, R. W., Murphy, B. M., and Manning, M. C. (2011). Product development issues for PEGylated proteins. Pharm. Dev. Technol. 16, 423-440. doi: 10.3109/10837450.2010.513990
62. Pisal, D. S., Kosloski, M. P., and Balu-Iyer, S. V. (2010). Delivery of therapeutic proteins. J. Pharm. Sci. 99, 2557-2575. doi: 10.1002/jps.22054
63. Plumbridge, J., and Soll, D. (1987). The effect of dam methylation on the expression of glnS in E. coli. Biochimie 69, 539-541. doi: 10.1016/0300-9084(87)90091-5
64. Prescher, J. A., and Bertozzi, C. R. (2005). Chemistry in living systems. Nat. Chem. Biol. 1, 13-21. doi: 10.1038/nchembio0605-13
65. Rackham, O., and Chin, J. W. (2005). A network of orthogonal ribosome x mRNA pairs. Nat. Chem. Biol. 1, 159-166. doi: 10.1038/nchembio719
66. Ryu, Y., and Schultz, P. G. (2006). Efficient incorporation of unnatural amino acids into proteins in Escherichia coli. Nat. Methods 3, 263-265. doi: 10.1038/nmeth864
67. Salinas, G., Pellizza, L., Margenat, M., Flo, M., and Fernandez, C. (2011). Tuned Escherichia coli as a host for the expression of disulfide-rich proteins. Biotechnol. J. 6, 686-699. doi: 10.1002/biot.201000335
68. Santoro, S. W., Wang, L., Herberich, B., King, D. S., and Schultz, P. G. (2002). An efficient system for the evolution of aminoacyl-tRNA synthetase specificity. Nat. Biotechnol. 20, 1044-1048. doi: 10.1038/nbt742
69. Schwarz, F., Huang, W., Li, C., Schulz, B. L., Lizak, C., Palumbo, A., et al. (2010). A combined method for producing homogeneous glycoproteins with eukaryotic N-glycosylation. Nat. Chem. Biol. 6, 264-266. doi: 10.1038/nchembio.314
70. Scolnick, E., Tompkins, R., Caskey, T., and Nirenberg, M. (1968). Release factors differing in specificity for terminator codons. Proc. Natl. Acad. Sci. U.S.A. 61, 768-774. doi: 10.1073/pnas.61.2.768
71. Seliger, B. (2008). Molecular mechanisms of MHC class I abnormalities and APM components in human tumors. Cancer Immunol. Immunother. 57, 1719-1726. doi: 10.1007/s00262-008-0515-4
72. Senter, P. D. (2009). Potent antibody drug conjugates for cancer therapy. Curr. Opin. Chem. Biol. 13, 235-244. doi: 10.1016/j.cbpa.2009.03.023
73. Sharpless, K. B. (2002). Searching for new reactivity (Nobel lecture). Angew. Chem. Int. Ed. Engl. 41, 2024-2032. doi: 10.1002/1521-3773(20020617)41:12%3C2024::AID-ANIE2024%3E3.0.CO;2-O
74. Shen, B. Q., Xu, K., Liu, L., Raab, H., Bhakta, S., Kenrick, M., et al. (2012). Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates. Nat. Biotechnol. 30, 184-189. doi: 10.1038/nbt.2108
75. Sletten, E. M., and Bertozzi, C. R. (2009). Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. Angew. Chem. Int. Ed. Engl. 48, 6974-6998. doi: 10.1002/anie.200900942
76. Stadtman, T. C. (1996). Selenocysteine. Annu. Rev. Biochem. 65, 83-100. doi: 10.1146/annurev.bi.65.070196.000503
77. Steer, B. A., and Schimmel, P. (1999). Major anticodon-binding region missing from an archaebacterial tRNA synthetase. J. Biol. Chem. 274, 35601-35606. doi: 10.1074/jbc.274.50.35601
78. Strohl, W. R., and Knight, D. M. (2009). Discovery and development of biopharmaceuticals: current issues. Curr. Opin. Biotechnol. 20, 668-672. doi: 10.1016/j.copbio.2009.10.012
79. Takimoto, J. K., Dellas, N., Noel, J. P., and Wang, L. (2011). Stereochemical basis for engineered pyrrolysyl-tRNA synthetase and the efficient in vivo incorporation of structurally divergent non-native amino acids. ACS Chem. Biol. 6, 733-743. doi: 10.1021/cb200057a
80. Terra, V. S., Mills, D. C., Yates, L. E., Abouelhadid, S., Cuccui, J., and Wren, B. W. (2012). Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design. J. Med. Microbiol. 61, 919-926. doi: 10.1099/jmm.0.039438-0
81. Veronese, F. M., Caliceti, P., Schiavon, O., and Sergi, M. (2002). Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation. Adv. Drug Deliv. Rev. 54, 587-606. doi: 10.1016/S0169-409X(02)00029-7
82. Virdee, S., Kapadnis, P. B., Elliott, T., Lang, K., Madrzak, J., Nguyen, D. P., et al. (2011). Traceless and site-specific ubiquitination of recombinant proteins. J. Am. Chem. Soc. doi: 10.1021/ja202799r
83. Virdee, S., Ye, Y., Nguyen, D. P., Komander, D., and Chin, J. W. (2010). Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an OTU deubiquitinase. Nat. Chem. Biol. 6, 750-757. doi: 10.1038/nchembio.426
84. Wacker, M., Linton, D., Hitchen, P. G., Nita-Lazar, M., Haslam, S. M., North, S. J., et al. (2002). N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli. Science 298, 1790-1793. doi: 10.1126/science.298.5599.1790
85. Wang, K., Neumann, H., Peak-Chew, S. Y., and Chin, J. W. (2007). Evolved orthogonal ribosomes enhance the efficiency of synthetic genetic code expansion. Nat. Biotechnol. 25, 770-777. doi: 10.1038/nbt1314
86. Wang, K., Schmied, W. H., and Chin, J. W. (2012). Reprogramming the genetic code: from triplet to quadruplet codes. Angew. Chem. Int. Ed. Engl. 51, 2288-2297. doi: 10.1002/anie.201105016
87. Wang, L., Brock, A., Herberich, B., and Schultz, P. G. (2001). Expanding the genetic code of Escherichia coli. Science 292, 498-500. doi: 10.1126/science.1060077
88. Wang, L., and Schultz, P. G. (2001). A general approach for the generation of orthogonal tRNAs. Chem. Biol. 8, 883-890. doi: 10.1016/S1074-5521(01)00063-1
89. Wang, Q., Chan, T. R., Hilgraf, R., Fokin, V. V., Sharpless, K. B., and Finn, M. G. (2003). Bioconjugation by copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition. J. Am. Chem. Soc. 125, 3192-3193. doi: 10.1021/ja021381e
90. Winter, J., Neubauer, P., Glockshuber, R., and Rudolph, R. (2001). Increased production of human proinsulin in the periplasmic space of Escherichia coli by fusion to DsbA. J. Biotechnol. 84, 175-185. doi: 10.1016/S0168-1656(00)00356-4
91. Xie, J., and Schultz, P. G. (2005a). Adding amino acids to the genetic repertoire. Curr. Opin. Chem. Biol. 9, 548-554. doi: 10.1016/j.cbpa.2005.10.011
92. Xie, J., and Schultz, P. G. (2005b). An expanding genetic code. Methods 36, 227-238. doi: 10.1016/j.ymeth.2005.04.010
93. Young, D. D., Young, T. S., Jahnz, M., Ahmad, I., Spraggon, G., and Schultz, P. G. (2011). An evolved aminoacyl-tRNA synthetase with atypical polysubstrate specificity. Biochemistry 50, 1894-1900. doi: 10.1021/bi101929e
94. Young, T. S., Ahmad, I., Yin, J. A., and Schultz, P. G. (2010). An enhanced system for unnatural amino acid mutagenesis in E. coli. J. Mol. Biol. 395, 361-374. doi: 10.1016/j.jmb.2009.10.030
95. Zhu, Z., and Carter, P. (1995). Identification of heavy chain residues in a humanized anti-CD3 antibody important for efficient antigen binding and T cell activation. J. Immunol. 155, 1903-1910.